{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:32:45Z","timestamp":1793331165589,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Crimean-Congo hemorrhagic fever (CCHF) is a widespread disease transmitted to humans and livestock animals through the bite of infected ticks or close contact with infected persons\u2019 blood, organs, or other bodily fluids. The virus is responsible for severe viral hemorrhagic fever outbreaks, with a case fatality rate of up to 40%. Despite having the highest fatality rate of the virus, a suitable treatment option or vaccination has not been developed yet. Therefore, this study aimed to formulate a multiepitope vaccine against CCHF through computational vaccine design approaches.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The glycoprotein, nucleoprotein, and RNA-dependent RNA polymerase of CCHF were utilized to determine \ufeffimmunodominant\ufeff T- and B-cell epitopes.\u00a0Subsequently, an integrative computational vaccinology approach was used to formulate a multi-epitopes\u00a0vaccine candidate against the virus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After rigorous assessment, a multiepitope vaccine was constructed, which was antigenic, immunogenic, and non-allergenic with desired physicochemical properties. Molecular dynamics (MD) simulations of the vaccine-receptor complex show strong stability of the vaccine candidates to the targeted immune receptor. Additionally, the immune simulation of the vaccine candidates found that the vaccine could trigger real-life-like immune responses upon administration to humans.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Finally, we concluded that the formulated multiepitope vaccine candidates would provide excellent prophylactic properties against CCHF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-02750-9","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T20:03:12Z","timestamp":1675281792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever"],"prefix":"10.1186","volume":"21","author":[{"given":"Rahat","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdus","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foysal","family":"Ahammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suza Mohammad","family":"Nur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad Amer","family":"Alsaiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raihan Rahman","family":"Imon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Enamul Kabir","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulkar","family":"Nain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Mashiar","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6599-9204","authenticated-orcid":false,"given":"Tomasz M.","family":"Karpi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"issue":"20","key":"2750_CR1","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1128\/JVI.01555-12","volume":"86","author":"SD Carter","year":"2012","unstructured":"Carter SD, et al. Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J Virol. 2012;86(20):10914\u201323.","journal-title":"J Virol"},{"issue":"3","key":"2750_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","volume":"64","author":"CA Whitehouse","year":"2004","unstructured":"Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64(3):145\u201360.","journal-title":"Antiviral Res"},{"issue":"7","key":"2750_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1086\/500836","volume":"193","author":"O Ergonul","year":"2006","unstructured":"Ergonul O, et al. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193(7):941\u20134.","journal-title":"J Infect Dis"},{"issue":"1","key":"2750_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","volume":"100","author":"DA Bente","year":"2013","unstructured":"Bente DA, et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100(1):159\u201389.","journal-title":"Antiviral Res"},{"issue":"4","key":"2750_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/jmedent\/15.4.307","volume":"15","author":"H Hoogstraal","year":"1979","unstructured":"Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979;15(4):307\u2013417.","journal-title":"J Med Entomol"},{"key":"2750_CR6","doi-asserted-by":"publisher","first-page":"103160","DOI":"10.1016\/j.jbi.2019.103160","volume":"93","author":"M Nosrati","year":"2019","unstructured":"Nosrati M, Behbahani M, Mohabatkar H. Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: a computer-aided vaccine design approach. J Biomed Inform. 2019;93:103160.","journal-title":"J Biomed Inform"},{"issue":"Suppl 4","key":"2750_CR7","doi-asserted-by":"publisher","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","volume":"11","author":"R Swanepoel","year":"1989","unstructured":"Swanepoel R, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11(Suppl 4):S794-800.","journal-title":"Rev Infect Dis"},{"issue":"3","key":"2750_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1309\/LMN1P2FRZ7BKZSCO","volume":"46","author":"S Shayan","year":"2015","unstructured":"Shayan S, et al. Crimean-Congo hemorrhagic fever. Lab Med. 2015;46(3):180\u20139.","journal-title":"Lab Med"},{"issue":"4","key":"2750_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s10989-022-10430-0","volume":"28","author":"MA Imran","year":"2022","unstructured":"Imran MA, et al. Development of multi-epitope based subunit vaccine against Crimean-Congo hemorrhagic fever virus using reverse vaccinology approach. Int J Pept Res Ther. 2022;28(4):124.","journal-title":"Int J Pept Res Ther"},{"issue":"7","key":"2750_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/v13071195","volume":"13","author":"S Dai","year":"2021","unstructured":"Dai S, et al. Crimean-Congo hemorrhagic fever virus: current advances and future prospects of antiviral strategies. Viruses. 2021;13(7):1195.","journal-title":"Viruses"},{"issue":"1","key":"2750_CR11","doi-asserted-by":"publisher","first-page":"120139","DOI":"10.1098\/rsob.120139","volume":"3","author":"A Patronov","year":"2013","unstructured":"Patronov A, Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open Biol. 2013;3(1):120139.","journal-title":"Open Biol"},{"key":"2750_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/1743-422X-7-351","volume":"7","author":"Z Stanekov\u00e1","year":"2010","unstructured":"Stanekov\u00e1 Z, Vare\u010dkov\u00e1 E. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virol J. 2010;7:351.","journal-title":"Virol J"},{"key":"2750_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.22.431920","volume-title":"Designing of multiepitope-based vaccine against leptospirosis using immuno-informatics approaches","author":"M Abdullah","year":"2021","unstructured":"Abdullah M, et al. Designing of multiepitope-based vaccine against leptospirosis using immuno-informatics approaches. 2021."},{"issue":"5\u20136","key":"2750_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3233\/ISB-2010-0435","volume":"10","author":"S Chakraborty","year":"2010","unstructured":"Chakraborty S, et al. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions. In Silico Biol. 2010;10(5\u20136):235\u201346.","journal-title":"In Silico Biol"},{"issue":"1","key":"2750_CR15","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41598-019-39299-8","volume":"9","author":"V Chauhan","year":"2019","unstructured":"Chauhan V, et al. Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach. Sci Rep. 2019;9(1):2517.","journal-title":"Sci Rep"},{"issue":"1","key":"2750_CR16","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.1038\/s41598-020-67749-1","volume":"10","author":"T Kar","year":"2020","unstructured":"Kar T, et al. A candidate multi-epitope vaccine against SARS-CoV-2. Sci Rep. 2020;10(1):10895.","journal-title":"Sci Rep"},{"issue":"2","key":"2750_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2017.92","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L. Multi-epitope vaccines: a promising strategy against tumors and viral infections. Cell Mol Immunol. 2018;15(2):182\u20134.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"2750_CR18","doi-asserted-by":"publisher","first-page":"e0006149","DOI":"10.1371\/journal.pntd.0006149","volume":"11","author":"D Goedhals","year":"2017","unstructured":"Goedhals D, Paweska JT, Burt FJ. Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection. PLoS Negl Trop Dis. 2017;11(12):e0006149.","journal-title":"PLoS Negl Trop Dis"},{"issue":"20","key":"2750_CR19","doi-asserted-by":"publisher","first-page":"10219","DOI":"10.1128\/JVI.01643-15","volume":"89","author":"JR Spengler","year":"2015","unstructured":"Spengler JR, et al. RIG-I mediates an antiviral response to Crimean-Congo hemorrhagic fever virus. J Virol. 2015;89(20):10219\u201329.","journal-title":"J Virol"},{"key":"2750_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s40475-016-0068-0","volume":"3","author":"M Arasli","year":"2016","unstructured":"Arasli M. Pathogenesis of Crimean-Congo hemorrhagic fever from an immunological perspective. Curr Trop Med Rep. 2016;3:14\u20139.","journal-title":"Curr Trop Med Rep"},{"issue":"14","key":"2750_CR21","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1128\/JVI.76.14.7263-7275.2002","volume":"76","author":"AJ Sanchez","year":"2002","unstructured":"Sanchez AJ, Vincent MJ, Nichol ST. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J Virol. 2002;76(14):7263\u201375.","journal-title":"J Virol"},{"issue":"2","key":"2750_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.virol.2006.11.023","volume":"361","author":"BR Erickson","year":"2007","unstructured":"Erickson BR, et al. N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport. Virology. 2007;361(2):348\u201355.","journal-title":"Virology"},{"issue":"24","key":"2750_CR23","doi-asserted-by":"publisher","first-page":"21678","DOI":"10.1074\/jbc.M110.216515","volume":"286","author":"DF Estrada","year":"2011","unstructured":"Estrada DF, De Guzman RN. Structural characterization of the Crimean-Congo hemorrhagic fever virus Gn tail provides insight into virus assembly. J Biol Chem. 2011;286(24):21678\u201386.","journal-title":"J Biol Chem"},{"issue":"3","key":"2750_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1681\/ASN.2007060684","volume":"19","author":"J Scholz","year":"2008","unstructured":"Scholz J, et al. Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. J Am Soc Nephrol. 2008;19(3):527\u201337.","journal-title":"J Am Soc Nephrol"},{"issue":"Database issue","key":"2750_CR25","doi-asserted-by":"publisher","first-page":"D593","DOI":"10.1093\/nar\/gkr859","volume":"40","author":"BE Pickett","year":"2012","unstructured":"Pickett BE, et al. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 2012;40(Database issue):D593-8.","journal-title":"Nucleic Acids Res"},{"key":"2750_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4.","journal-title":"BMC Bioinformatics"},{"key":"2750_CR27","doi-asserted-by":"publisher","first-page":"863985","DOI":"10.1155\/2010\/863985","volume":"2010","author":"M Schotsaert","year":"2010","unstructured":"Schotsaert M, et al. Controlling influenza by cytotoxic T-cells: calling for help from destroyers. J Biomed Biotechnol. 2010;2010:863985.","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"2750_CR28","first-page":"276","volume":"43","author":"AJ McMichael","year":"1981","unstructured":"McMichael AJ, et al. The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol. 1981;43(2):276\u201384.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2750_CR29","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.1038\/s41598-021-86986-6","volume":"11","author":"N Kumar","year":"2021","unstructured":"Kumar N, et al. Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework. Sci Rep. 2021;11(1):7653.","journal-title":"Sci Rep"},{"issue":"6","key":"2750_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nri819","volume":"2","author":"M Barry","year":"2002","unstructured":"Barry M, Bleackley RC. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2002;2(6):401\u20139.","journal-title":"Nat Rev Immunol"},{"key":"2750_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV, et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics. 2007;8:424.","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"2750_CR32","doi-asserted-by":"publisher","first-page":"W502","DOI":"10.1093\/nar\/gkz452","volume":"47","author":"SK Dhanda","year":"2019","unstructured":"Dhanda SK, et al. IEDB-AR: immune epitope database-analysis resource in 2019. Nucleic Acids Res. 2019;47(W1):W502-w506.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2750_CR33","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta S, et al. In silico approach for predicting toxicity of peptides and proteins. PLoS ONE. 2013;8(9):e73957.","journal-title":"PLoS ONE"},{"issue":"6","key":"2750_CR34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","volume":"30","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, et al. AllergenFP: allergenicity prediction by descriptor fingerprints. Bioinformatics. 2014;30(6):846\u201351.","journal-title":"Bioinformatics"},{"issue":"6","key":"2750_CR35","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, et al. AllerTOP vol 2\u2013a server for in silico prediction of allergens. J Mol Model. 2014;20(6):2278.","journal-title":"J Mol Model"},{"key":"2750_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-323-07447-6.00004-1","volume-title":"Elsevier\u2019s integrated review immunology and microbiology (second edition)","author":"JK Actor","year":"2012","unstructured":"Actor JK. 4 - T-cell immunity. In: Actor JK, editor. Elsevier\u2019s integrated review immunology and microbiology (second edition). Philadelphia: W.B. Saunders; 2012. p. 25\u201332."},{"key":"2750_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vacrep.2016.07.002","volume":"6","author":"T Ahmad","year":"2016","unstructured":"Ahmad T, Ewida A, El-Sayed L. T-cell epitope mapping for the design of powerful vaccines. Vaccine Reports. 2016;6:13\u201322.","journal-title":"Vaccine Reports"},{"issue":"2","key":"2750_CR38","doi-asserted-by":"publisher","first-page":"e14643","DOI":"10.1371\/journal.pone.0014643","volume":"6","author":"S Buhler","year":"2011","unstructured":"Buhler S, Sanchez-Mazas A. HLA DNA sequence variation among human populations: molecular signatures of demographic and selective events. PLoS ONE. 2011;6(2):e14643.","journal-title":"PLoS ONE"},{"key":"2750_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.gdata.2016.11.012","volume":"11","author":"F Shahsavar","year":"2017","unstructured":"Shahsavar F, Varzi AM, Ahmadi SA. A genomic study on distribution of human leukocyte antigen (HLA)-A and HLA-B alleles in Lak population of Iran. Genom Data. 2017;11:3\u20136.","journal-title":"Genom Data"},{"key":"2750_CR40","doi-asserted-by":"publisher","first-page":"746151","DOI":"10.1155\/2015\/746151","volume":"2015","author":"M Tshabalala","year":"2015","unstructured":"Tshabalala M, Mellet J, Pepper MS. Human leukocyte antigen diversity: a Southern African perspective. J Immunol Res. 2015;2015:746151.","journal-title":"J Immunol Res"},{"key":"2750_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui HH, et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics. 2006;7:153.","journal-title":"BMC Bioinformatics"},{"key":"2750_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.compbiolchem.2016.04.006","volume":"62","author":"N Nezafat","year":"2016","unstructured":"Nezafat N, et al. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Comput Biol Chem. 2016;62:82\u201395.","journal-title":"Comput Biol Chem"},{"issue":"1","key":"2750_CR43","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1038\/s41598-019-40833-x","volume":"9","author":"RA Shey","year":"2019","unstructured":"Shey RA, et al. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Sci Rep. 2019;9(1):4409.","journal-title":"Sci Rep"},{"issue":"1","key":"2750_CR44","doi-asserted-by":"publisher","first-page":"20864","DOI":"10.1038\/s41598-020-77547-4","volume":"10","author":"E Behmard","year":"2020","unstructured":"Behmard E, et al. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2. Sci Rep. 2020;10(1):20864.","journal-title":"Sci Rep"},{"issue":"6","key":"2750_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran B, et al. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021;20(6):454\u201375. https:\/\/doi.org\/10.1038\/s41573-021-00163-y.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"2750_CR46","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","volume":"19","author":"SG Reed","year":"2013","unstructured":"Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19(12):1597\u2013608.","journal-title":"Nat Med"},{"issue":"5","key":"2750_CR47","first-page":"779","volume":"138","author":"T Mohan","year":"2013","unstructured":"Mohan T, Verma P, Rao DN. Novel adjuvants & delivery vehicles for vaccines development: a road ahead. Indian J Med Res. 2013;138(5):779\u201395.","journal-title":"Indian J Med Res"},{"issue":"10","key":"2750_CR48","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/jmv.24519","volume":"88","author":"A Engin","year":"2016","unstructured":"Engin A, et al. Is there any relationship between Toll-like receptor 3 c1377C\/T and -7C\/A polymorphisms and susceptibility to Crimean Congo hemorrhagic fever? J Med Virol. 2016;88(10):1690\u20136.","journal-title":"J Med Virol"},{"issue":"12\u201313","key":"2750_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.micinf.2010.07.012","volume":"12","author":"A Engin","year":"2010","unstructured":"Engin A, et al. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect. 2010;12(12\u201313):1071\u20138.","journal-title":"Microbes Infect"},{"key":"2750_CR50","doi-asserted-by":"crossref","unstructured":"Bhuiyan, M., et al., Discovery of potential immune epitopes and peptide vaccine design - a prophylactic strategy against Rift Valley fever virus [version 1; peer review: 2 approved with reservations]. 2020. 9(999).","DOI":"10.12688\/f1000research.24975.1"},{"key":"2750_CR51","doi-asserted-by":"publisher","first-page":"e9541","DOI":"10.7717\/peerj.9541","volume":"8","author":"T Zaheer","year":"2020","unstructured":"Zaheer T, et al. Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences. PeerJ. 2020;8:e9541.","journal-title":"PeerJ"},{"key":"2750_CR52","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3389\/fimmu.2020.01784","volume":"11","author":"R Dong","year":"2020","unstructured":"Dong R, et al. Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches. Front Immunol. 2020;11:1784.","journal-title":"Front Immunol"},{"key":"2750_CR53","doi-asserted-by":"publisher","first-page":"103791","DOI":"10.1016\/j.micpath.2019.103791","volume":"137","author":"F Abdulla","year":"2019","unstructured":"Abdulla F, Adhikari UK, Uddin MK. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach. Microb Pathog. 2019;137:103791.","journal-title":"Microb Pathog"},{"issue":"5","key":"2750_CR54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1586\/14760584.2014.907528","volume":"13","author":"AK Dey","year":"2014","unstructured":"Dey AK, Malyala P, Singh M. Physicochemical and functional characterization of vaccine antigens and adjuvants. Expert Rev Vaccines. 2014;13(5):671\u201385.","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"2750_CR55","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.drudis.2021.03.007","volume":"26","author":"Z Dong","year":"2021","unstructured":"Dong Z, et al. Effects on immunization of the physicochemical parameters of particles as vaccine carriers. Drug Discov Today. 2021;26(7):1712\u201320.","journal-title":"Drug Discov Today"},{"key":"2750_CR56","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The proteomics protocols handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E, et al. Protein identification and analysis tools on the ExPASy server. In: Walker JM, editor., et al., The proteomics protocols handbook. Totowa, NJ: Humana Press; 2005. p. 571\u2013607."},{"issue":"17","key":"2750_CR57","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","volume":"25","author":"CN Magnan","year":"2009","unstructured":"Magnan CN, Randall A, Baldi P. SOLpro: accurate sequence-based prediction of protein solubility. Bioinformatics. 2009;25(17):2200\u20137.","journal-title":"Bioinformatics"},{"issue":"19","key":"2750_CR58","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch M, et al. Protein-Sol: a web tool for predicting protein solubility from sequence. Bioinformatics. 2017;33(19):3098\u2013100.","journal-title":"Bioinformatics"},{"issue":"8","key":"2750_CR59","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/nprot.2012.085","volume":"7","author":"M K\u00e4llberg","year":"2012","unstructured":"K\u00e4llberg M, et al. Template-based protein structure modeling using the RaptorX web server. Nat Protoc. 2012;7(8):1511\u201322.","journal-title":"Nat Protoc"},{"issue":"Web Server issu","key":"2750_CR60","doi-asserted-by":"publisher","first-page":"W294","DOI":"10.1093\/nar\/gks493","volume":"40","author":"J Ko","year":"2012","unstructured":"Ko J, et al. GalaxyWEB server for protein structure prediction and refinement. Nucleic Acids Res. 2012;40(Web Server issue):W294-7.","journal-title":"Nucleic Acids Res"},{"key":"2750_CR61","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35:W407-10.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2750_CR62","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511\u20139.","journal-title":"Protein Sci"},{"key":"2750_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-2836(63)80023-6","volume":"7","author":"GN Ramachandran","year":"1963","unstructured":"Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol. 1963;7:95\u20139.","journal-title":"J Mol Biol"},{"issue":"3","key":"2750_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"SC Lovell","year":"2003","unstructured":"Lovell SC, et al. Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins. 2003;50(3):437\u201350.","journal-title":"Proteins"},{"key":"2750_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1472-6807-5-14","volume":"5","author":"BK Ho","year":"2005","unstructured":"Ho BK, Brasseur R. The Ramachandran plots of glycine and pre-proline. BMC Struct Biol. 2005;5:14.","journal-title":"BMC Struct Biol"},{"key":"2750_CR66","first-page":"105235","volume":"143","author":"A Mehmood","year":"2022","unstructured":"Mehmood A, et al. Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach. 2022;143:105235.","journal-title":"A medicinal chemistry approach"},{"issue":"7","key":"2750_CR67","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/jmv.24174","volume":"87","author":"S Arslan","year":"2015","unstructured":"Arslan S, et al. Toll-like receptor 7 Gln11Leu, c.4\u2013151A\/G, and +1817G\/T polymorphisms in Crimean Congo hemorrhagic fever. J Med Virol. 2015;87(7):1090\u20135.","journal-title":"J Med Virol"},{"issue":"12","key":"2750_CR68","doi-asserted-by":"publisher","first-page":"e1007390","DOI":"10.1371\/journal.ppat.1007390","volume":"14","author":"J Olejnik","year":"2018","unstructured":"Olejnik J, Hume AJ, M\u00fchlberger E. Toll-like receptor 4 in acute viral infection: too much of a good thing. PLoS Pathog. 2018;14(12):e1007390.","journal-title":"PLoS Pathog"},{"issue":"3","key":"2750_CR69","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/prot.25219","volume":"85","author":"S Vajda","year":"2017","unstructured":"Vajda S, et al. New additions to the ClusPro server motivated by CAPRI. Proteins. 2017;85(3):435\u201344.","journal-title":"Proteins"},{"issue":"9","key":"2750_CR70","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1021\/acs.jctc.8b00225","volume":"14","author":"H Hogues","year":"2018","unstructured":"Hogues H, et al. ProPOSE: direct exhaustive protein\u2013protein docking with side chain flexibility. J Chem Theory Comput. 2018;14(9):4938\u201347.","journal-title":"J Chem Theory Comput"},{"key":"2750_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2018.12.010","volume":"55","author":"KA Porter","year":"2019","unstructured":"Porter KA, et al. What method to use for protein\u2013protein docking? Curr Opin Struct Biol. 2019;55:1\u20137.","journal-title":"Curr Opin Struct Biol"},{"issue":"11","key":"2750_CR72","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/prot.24343","volume":"81","author":"V Sandor","year":"2013","unstructured":"Sandor V, Kozakov DJP. Sampling and scoring: a marriage made in heaven. Proteins. 2013;81(11):1874.","journal-title":"Proteins"},{"issue":"2","key":"2750_CR73","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, et al. The ClusPro web server for protein-protein docking. Nat Protoc. 2017;12(2):255\u201378.","journal-title":"Nat Protoc"},{"issue":"8","key":"2750_CR74","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/prot.24551","volume":"82","author":"K Zhu","year":"2014","unstructured":"Zhu K, et al. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction. Proteins. 2014;82(8):1646\u201355.","journal-title":"Proteins"},{"issue":"2","key":"2750_CR75","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1021\/acs.jcim.0c00488","volume":"61","author":"A Mehmood","year":"2021","unstructured":"Mehmood A, et al. Bringing structural implications and deep learning-based drug identification for KRAS mutants. J Chem Inf Model. 2021;61(2):571\u201386.","journal-title":"J Chem Inf Model"},{"key":"2750_CR76","unstructured":"Proceedings of the 2006 ACM\/IEEE conference on Supercomputing. 2006. Tampa, Florida: Association for Computing Machinery."},{"issue":"3","key":"2750_CR77","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G MadhaviSastry","year":"2013","unstructured":"MadhaviSastry G, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27(3):221\u201334.","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"2750_CR78","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder E, et al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput. 2016;12(1):281\u201396.","journal-title":"J Chem Theory Comput"},{"issue":"12","key":"2750_CR79","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1039\/D2RA00277A","volume":"12","author":"A Khan","year":"2022","unstructured":"Khan A, et al. Blocking key mutated hotspot residues in the RBD of the omicron variant (B.1.1.529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches. RSC Advances. 2022;12(12):7318\u201327.","journal-title":"RSC Advances"},{"issue":"43","key":"2750_CR80","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A. 2001;105(43):9954\u201360.","journal-title":"J Phys Chem A"},{"issue":"63","key":"2750_CR81","doi-asserted-by":"publisher","first-page":"40120","DOI":"10.1039\/D1RA06842C","volume":"11","author":"R Alam","year":"2021","unstructured":"Alam R, et al. GC-MS analysis of phytoconstituents from Ruellia prostrata and Senna tora and identification of potential anti-viral activity against SARS-CoV-2. RSC Adv. 2021;11(63):40120\u201335.","journal-title":"RSC Adv"},{"key":"2750_CR82","doi-asserted-by":"publisher","unstructured":"Ahammad F, et al. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein.\u00a0Brief Bioinform.\u00a02021;22(5):bbab098. https:\/\/doi.org\/10.1093\/bib\/bbab098.","DOI":"10.1093\/bib\/bbab098"},{"key":"2750_CR83","doi-asserted-by":"publisher","unstructured":"Banerjee S, Majumder K, Gutierrez GJ, Gupta D, Mittal B. Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2. bioRxiv [Preprint]. 2020:2020.07.23.218529. https:\/\/doi.org\/10.1101\/2020.07.23.218529. PMID: 32743567; PMCID: PMC7386484.","DOI":"10.1101\/2020.07.23.218529"},{"issue":"4","key":"2750_CR84","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, et al. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS ONE. 2010;5(4):e9862.","journal-title":"PLoS ONE"},{"issue":"1","key":"2750_CR85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/07391102.2020.1792347","volume":"40","author":"A Samad","year":"2022","unstructured":"Samad A, et al. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. J Biomol Struct Dyn. 2022;40(1):14\u201330.","journal-title":"J Biomol Struct Dyn"},{"issue":"16","key":"2750_CR86","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1080\/07391102.2019.1692072","volume":"38","author":"Z Nain","year":"2020","unstructured":"Nain Z, et al. Proteome-wide screening for designing a multi-epitope vaccine against emerging pathogen Elizabethkingia anophelis using immunoinformatic approaches. J Biomol Struct Dyn. 2020;38(16):4850\u201367.","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"2750_CR87","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s10989-019-10003-8","volume":"26","author":"SB Sayed","year":"2020","unstructured":"Sayed SB, et al. Exploring Lassa virus proteome to design a multi-epitope vaccine through immunoinformatics and immune simulation analyses. Int J Pept Res Ther. 2020;26(4):2089\u2013107.","journal-title":"Int J Pept Res Ther"},{"key":"2750_CR88","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1471-2105-12-251","volume":"12","author":"Y Wang","year":"2011","unstructured":"Wang Y, et al. Determinants of antigenicity and specificity in immune response for protein sequences. BMC Bioinformatics. 2011;12:251.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"2750_CR89","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12250-011-3209-6","volume":"26","author":"ZR Zhou","year":"2011","unstructured":"Zhou ZR, et al. Production of CCHF virus-like particle by a baculovirus-insect cell expression system. Virologica Sinica. 2011;26(5):338\u201346.","journal-title":"Virologica Sinica"},{"issue":"2","key":"2750_CR90","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/21645515.2015.1078045","volume":"12","author":"SD Dowall","year":"2016","unstructured":"Dowall SD, et al. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Hum Vaccin Immunother. 2016;12(2):519\u201327.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"2750_CR91","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/protein\/14.8.529","volume":"14","author":"R Arai","year":"2001","unstructured":"Arai R, et al. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 2001;14(8):529\u201332.","journal-title":"Protein Eng"},{"issue":"10","key":"2750_CR92","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65(10):1357\u201369.","journal-title":"Adv Drug Deliv Rev"},{"key":"2750_CR93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.compbiomed.2016.06.015","volume":"76","author":"S Shamriz","year":"2016","unstructured":"Shamriz S, Ofoghi H, Moazami N. Effect of linker length and residues on the structure and stability of a fusion protein with malaria vaccine application. Comput Biol Med. 2016;76:24\u20139.","journal-title":"Comput Biol Med"},{"issue":"3","key":"2750_CR94","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1021\/acsomega.8b03391","volume":"4","author":"CH Kapadia","year":"2019","unstructured":"Kapadia CH, et al. Role of linker length and antigen density in nanoparticle peptide vaccine. ACS Omega. 2019;4(3):5547\u201355.","journal-title":"ACS Omega"},{"issue":"1","key":"2750_CR95","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1038\/s41598-017-09199-w","volume":"7","author":"M Ali","year":"2017","unstructured":"Ali M, et al. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection. Sci Rep. 2017;7(1):9232.","journal-title":"Sci Rep"},{"issue":"5","key":"2750_CR96","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/vaccines10050819","volume":"10","author":"A Facciol\u00e0","year":"2022","unstructured":"Facciol\u00e0 A, et al. An overview of vaccine adjuvants: current evidence and future perspectives. Vaccines. 2022;10(5):819.","journal-title":"Vaccines"},{"issue":"1","key":"2750_CR97","doi-asserted-by":"publisher","first-page":"15983","DOI":"10.1038\/s41598-022-20397-z","volume":"12","author":"SW Shantier","year":"2022","unstructured":"Shantier SW, et al. Novel multi epitope-based vaccine against monkeypox virus: vaccinomic approach. Sci Rep. 2022;12(1):15983.","journal-title":"Sci Rep"},{"issue":"1","key":"2750_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43141-020-00049-3","volume":"18","author":"A Sahay","year":"2020","unstructured":"Sahay A, et al. In silico analysis and homology modeling of strictosidine synthase involved in alkaloid biosynthesis in Catharanthus roseus. J Genet Eng Biotechnol. 2020;18(1):1\u20136.","journal-title":"J Genet Eng Biotechnol"},{"issue":"10","key":"2750_CR99","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00262-022-03181-w","volume":"71","author":"A Samad","year":"2022","unstructured":"Samad A, et al. Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches. Cancer Immunol Immunother. 2022;71(10):2535\u201348.","journal-title":"Cancer Immunol Immunother"},{"key":"2750_CR100","doi-asserted-by":"publisher","first-page":"101693","DOI":"10.1016\/j.mcp.2020.101693","volume":"55","author":"MSA Khan","year":"2021","unstructured":"Khan MSA, et al. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus. Mol Cell Probes. 2021;55:101693.","journal-title":"Mol Cell Probes"},{"key":"2750_CR101","first-page":"5","volume-title":"Toll-like receptor signaling pathways","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. 2014. p. 5."},{"key":"2750_CR102","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874285800802010049","volume":"2","author":"A Xagorari","year":"2008","unstructured":"Xagorari A, Chlichlia K. Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol J. 2008;2:49\u201359.","journal-title":"Open Microbiol J"},{"issue":"5","key":"2750_CR103","doi-asserted-by":"publisher","first-page":"e1010485","DOI":"10.1371\/journal.ppat.1010485","volume":"18","author":"JW Golden","year":"2022","unstructured":"Golden JW, et al. The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice. PLoS Pathog. 2022;18(5):e1010485.","journal-title":"PLoS Pathog"},{"issue":"4","key":"2750_CR104","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.sjbs.2021.12.004","volume":"29","author":"M Sana","year":"2022","unstructured":"Sana M, et al. Development of multivalent vaccine targeting M segment of Crimean Congo Hemorrhagic Fever Virus (CCHFV) using immunoinformatic approaches. Saudi J Biol Sci. 2022;29(4):2372\u201388.","journal-title":"Saudi J Biol Sci"},{"key":"2750_CR105","first-page":"12","volume-title":"Development of a novel multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus: an integrated reverse vaccinology, vaccine informatics and biophysics approach","author":"M Tahir Ul Qamar","year":"2021","unstructured":"Tahir Ul Qamar M, et al. Development of a novel multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus: an integrated reverse vaccinology, vaccine informatics and biophysics approach. 2021. p. 12."},{"issue":"1","key":"2750_CR106","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1038\/s41598-022-12651-1","volume":"12","author":"AA Omoniyi","year":"2022","unstructured":"Omoniyi AA, et al. In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches. Sci Rep. 2022;12(1):8736.","journal-title":"Sci Rep"},{"issue":"2","key":"2750_CR107","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/erv.09.160","volume":"9","author":"M Black","year":"2010","unstructured":"Black M, et al. Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines. 2010;9(2):157\u201373.","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"2750_CR108","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00430-009-0109-6","volume":"198","author":"K Huygen","year":"2009","unstructured":"Huygen K, et al. Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol. 2009;198(2):69\u201377.","journal-title":"Med Microbiol Immunol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02750-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02750-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02750-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T04:59:08Z","timestamp":1675486748000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02750-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2750"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02750-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"4 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}